Men's Health News
Scientists Discover A New Way To Read The Histone Code By Studying Streamlined Sperm
In the quest for speed, olympic swimmers shave themselves or squeeze into high-tech super-suits. In the body, sperm are the only cells that swim and, as speed is crucial to fertility, have developed their own ways to become exceptionally streamlined. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and Grenoble, the Institut de Biologie Structurale (IBS) and the Institut Albert Bonniot, both also in Grenoble, have been studying the secrets of speedy sperm.
Categories: Men's Health News
Urologists, Radiologists, Patients Benefit From New Clinical Prostate Visualization System
The introduction of Invivo Corporation's DynaCAD for Prostate advanced clinical visualization and MR interventional system brings new hope to patients and new confidence to their care providers, a positive development this Prostate Cancer Awareness Month.
Categories: Men's Health News
Incept BioSystems Initiates First Human Clinical Trial Of Its SMART Embryo Culture System For In Vitro Fertilization (IVF)
Incept BioSystems, Inc. ("Incept" or the "Company"), a privately-held biomedical device company using patented microfluidic technology developed at the University of Michigan, announced today that it has initiated the first U.S. human clinical trial of its proprietary SMART Embryo Culture System.
Categories: Men's Health News
Robotic Surgery Expert Dr. David Samadi Advises Being Proactive In Prostate Cancer Treatment
When it comes to the prostate cancer, the disease known as the "silent killer" because it often exhibits no symptoms, to be forewarned is to be forearmed. It is the second leading cancer killer in men, just behind lung cancer. Every year, more than 218,000 men are diagnosed with prostate cancer in the United States, claiming about 28,000 lives.
Categories: Men's Health News
Not Enough Evidence To Support Routine Prostate Cancer Screening
There is insufficient evidence to support population-wide screening for prostate cancer using the prostate specific antigen (PSA) test, conclude two papers published on bmj.com today. The authors say that the PSA test cannot distinguish between lethal and harmless prostate cancer, leading to overdiagnosis and overtreatment of healthy men.
Categories: Men's Health News
What Is Infertility? What Causes Infertility? How Is Infertility Treated?
Infertility refers to an inability to conceive after having regular unprotected sex. Infertility can also refer to the biological inability of an individual to contribute to conception, or to a female who cannot carry a pregnancy to full term. In many countries infertility refers to a couple that has failed to conceive after 12 months of regular sexual intercourse without the use of contraception.
Categories: Men's Health News
Natural Products Association's Fabricant To Testify At Senate Hearing On Steroids And Sports Supplements
Daniel Fabricant, Ph.D., interim executive director and CEO of the Natural Products Association (NPA), will testify today before the Subcommittee on Crime and Drugs of the U.S. Senate Judiciary Committee during a hearing examining the illegal marketing of steroids as dietary supplements.
Categories: Men's Health News
Expert: Better Decision Support Tools Needed For Prostate Cancer Screening Choice
Although screening for prostate cancer with the Prostate Specific Antigen (PSA) test in men ages 50-70 can detect the cancer before it becomes symptomatic, knowing whether screening is beneficial for these men is uncertain. Recent trials have shown small or no reductions in prostate cancer mortality among those screened.
Categories: Men's Health News
Religion Impacts Decision On Prostate Cancer Screening In African-American Men
African-American men are more likely to have had a digital rectal exam in the past year to screen for prostate cancer if they engage in religious behaviors, according to a University of Alabama at Birmingham (UAB) study published in the American Journal of Men's Health. Study co-author Theresa A. Wynn, Ph.D.
Categories: Men's Health News
Strategies For Reducing Painful Breast Cancer Drug Side Effects
Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. New University of Pennsylvania School of Medicine research, however, has uncovered patterns that may help clinicians identify and help women at risk of these symptoms sooner in order to increase their chances of sticking with their treatment regimen.
Categories: Men's Health News
News From The American Journal Of Pathology, October 2009
B-Cell Lymphoma Protected by SPAK Silencing A group led by Dr. Michael Teitell at UCLA has demonstrated that misregulation of the protein SPAK may contribute to B-cell lymphoma development. Their report can be found in the October 2009 issue of the American Journal of Pathology. B-cell lymphomas are the most frequent human immune system cancers.
Categories: Men's Health News
Survey: Men May Not Be Adequately Involved In Decisions About Prostate Cancer Screening
Men largely make decisions about prostate cancer screening based on conversations with their clinicians, but these discussions often do not include information about the risks of testing in addition to the benefits, according to a report in the September 28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Categories: Men's Health News
Survival In Prostate Cancer Affected By Income, Swiss Study Finds
Prostate cancer patients of low socioeconomic status are more likely to die than patients with higher incomes. That is the finding of a new study from Swiss researchers to be published in the December 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society. The study's findings indicate that poor prostate cancer patients receive worse care than their wealthier counterparts.
Categories: Men's Health News
Researchers Find Few Side Effects From Radiation Treatment Given After Prostate Cancer Surgery
The largest single-institution study of its kind has found few complications in prostate cancer patients treated with radiotherapy after surgery to remove the prostate. Men in this study received radiotherapy after a prostate-specific antigen (PSA) test following surgery indicated their cancer had recurred.
Categories: Men's Health News
National Survey: Health Care Providers Unlikely To Tell Men About Prostate Cancer Screening Risks
Health care providers are twice as likely to discuss the benefits rather than the risks associated with PSA (Prostate Specific Antigen) testing, despite national guidelines recommending full disclosure before screening, according to the results of national survey of men age 40 and older published in the September 28 issue of the Archives of Internal Medicine.
Categories: Men's Health News
Free Prostate Cancer Screening Offered In Camden Oct. 10
Urology Centers of Alabama and the Wilcox County Health Department will sponsor a prostate cancer screening on Saturday, Oct. 10 from 10 a.m. to 2 p.m. at the health department located at 107 Union St. in Camden. In the past, more than 150 men have been provided free prostate screenings during the four-hour events. Prostate cancer is very treatable when detected early.
Categories: Men's Health News
Potential Relationship Between Androgen Deficiency And Cardiovascular Disease
Researchers from Boston University School of Medicine (BUSM) in collaboration with researchers from Lahey Clinic Northshore, Peabody, Mass., believe that androgen deficiency might be the underlying cause for a variety of common clinical conditions, including diabetes, erectile dysfunction, metabolic syndrome and cardiovascular disease (CVD). These findings appear in the September/October issue of the Journal of Andrology.
Categories: Men's Health News
Agressive Prostate Cancer Test Hope
Cancer Research UK scientists have discovered a molecular 'flag' that predicts survival from prostate cancer at diagnosis, reveals a study published in the British Journal of Cancer. The research led by pathologists based at the
Categories: Men's Health News
Anxiety And Distress During Active Surveillance For Early Prostate Cancer
UroToday.com - Men with low-risk prostate cancer (CaP) who are candidates for active surveillance (AS) often choose definitive therapy due to anxiety over their untreated cancer. In the September 1, 2009 issue of Cancer, a group of researchers from the Netherlands assessed anxiety and distress during AS for CaP.
Categories: Men's Health News
Active Biotech's Prostate Cancer Project TASQ Featured In British Journal Of Cancer
British Journal of Cancer (doi: 10.1038/sj.bjc.6605322) releases an article covering Active Biotech's (NASDAQ OMX Nordic: ACTI) prostate cancer project TASQ, where TASQ was studied as a single agent in patients with castration-resistant prostate cancer. Two open-label phase I clinical trials in patients with castration-resistant prostate cancer were conducted to evaluate the safety and tolerability of TASQ, with additional pharmacokinetic and efficacy assessments.
Categories: Men's Health News
